MedTrace Logo

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

NCT06807866 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-03-18

No results posted yet for this study

Summary

The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.

Conditions

  • THA

Interventions

DRUG

Duloxetine

Participants will come in person and receive a one time 60 mg dose by mouth.

OTHER

Placebo

Participants will come in person and receive a one time 60 mg placebo pill dose by mouth.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Victor Hernandez, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-12-01
Completion
2026-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807866 on ClinicalTrials.gov